Cannabis Bioscience International Holdings, Inc. (CBIH) Non Operating Income (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Non Operating Income across 5 years of filings, most recently posting -$10675.0 for Q1 2026.

• In Q1 2026, Non Operating Income rose 79.47% year-over-year to -$10675.0; the TTM figure through Feb 2026 stood at -$116470.0 (up 25.77% YoY), while the FY2025 annual figure was -$127455.0, up 22.85% from the prior year.
• Non Operating Income came in at -$10675.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$21090.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $21299.0 in Q3 2024 to a low of -$106302.0 in Q2 2024.
• Average Non Operating Income over 5 years is -$31049.9, with a median of -$25503.0 recorded in 2023.
• The largest YoY upside for Non Operating Income was 525.55% in 2024 against a maximum downside of 9502.71% in 2024.
• Over 5 years, Non Operating Income stood at -$36278.0 in 2022, then grew by 17.54% to -$29916.0 in 2023, then soared by 33.48% to -$19901.0 in 2024, then fell by 5.97% to -$21090.0 in 2025, then soared by 49.38% to -$10675.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$10675.0 in Q1 2026, -$21090.0 in Q4 2025, and -$7861.0 in Q3 2025.